Fluorescence-based bowel anastomosis perfusion evaluation: results from the IHU-IRCAD-EAES EURO-FIGS registry
Andrea Spota,Mahdi Al-Taher,Eric Felli,Salvador Morales Conde,Ivano Dal Dosso,Gianluigi Moretto,Giuseppe Spinoglio,Gianluca Baiocchi,Ramon Vilallonga,Harmony Impellizzeri,Gonzalo P Martin-Martin,Lorenzo Casali,Christian Franzini,Marta Silvestri,Nicolò de Manzini,Maurizio Castagnola,Marco Filauro,Davide Cosola,Catalin Copaescu,Giovanni Maria Garbarino,Antonio Pesce,Marcello Calabrò,Paola de Nardi,Gabriele Anania,Thomas Carus,Luigi Boni,Alessandro Patané,Caterina Santi,Alend Saadi,Alessio Rollo,Roland Chautems,José Noguera,Jan Grosek,Giancarlo D'Ambrosio,Carlos Marques Ferreira,Gregor Norcic,Giuseppe Navarra,Pietro Riva,Silvia Quaresima,Alessandro Paganini,Nunzio Rosso,Paolo De Paolis,Andrea Balla,Marc Olivier Sauvain,Eleftherios Gialamas,Giorgio Bianchi,Gaetano La Greca,Carlo Castoro,Andrea Picchetto,Alessandro Franchello,Luciano Tartamella,Robert Juvan,Orestis Ioannidis,Jurij Ales Kosir,Emilio Bertani,Laurents Stassen,Jacques Marescaux,Michele Diana
DOI: https://doi.org/10.1007/s00464-020-08234-8
Abstract:Background: Anastomotic leakage (AL) is one of the dreaded complications following surgery in the digestive tract. Near-infrared fluorescence (NIRF) imaging is a means to intraoperatively visualize anastomotic perfusion, facilitating fluorescence image-guided surgery (FIGS) with the purpose to reduce the incidence of AL. The aim of this study was to analyze the current practices and results of NIRF imaging of the anastomosis in digestive tract surgery through the EURO-FIGS registry. Methods: Analysis of data prospectively collected by the registry members provided patient and procedural data along with the ICG dose, timing, and consequences of NIRF imaging. Among the included upper-GI, colorectal, and bariatric surgeries, subgroup analysis was performed to identify risk factors associated with complications. Results: A total of 1240 patients were included in the study. The included patients, 74.8% of whom were operated on for cancer, originated from 8 European countries and 30 hospitals. A total of 54 surgeons performed the procedures. In 83.8% of cases, a pre-anastomotic ICG dose was administered, and in 60.1% of cases, a post-anastomotic ICG dose was administered. A significant difference (p < 0.001) was found in the ICG dose given in the four pathology groups registered (range: 0.013-0.89 mg/kg) and a significant (p < 0.001) negative correlation was found between the ICG dose and BMI. In 27.3% of the procedures, the choice of the anastomotic level was guided by means of NIRF imaging which means that in these cases NIRF imaging changed the level of anastomosis which was first decided based on visual findings in conventional white light imaging. In 98.7% of the procedures, the use of ICG partly or strongly provided a sense of confidence about the anastomosis. A total of 133 complications occurred, without any statistical significance in the incidence of complications in the anastomoses, whether they were ICG-guided or not. Conclusion: The EURO-FIGS registry provides an insight into the current clinical practice across Europe with respect to NIRF imaging of anastomotic perfusion during digestive tract surgery.